HY-P1048-1mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1048-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1048-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein (MBP) (68-82), guinea pig [CAS 98474-59-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P0251-1mg
|
MedChemexpress LLC
|
Neurotensin(8-13) [CAS 60482-95-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P0251-10mg
|
MedChemexpress LLC
|
Neurotensin(8-13) [CAS 60482-95-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P0251-25mg
|
MedChemexpress LLC
|
Neurotensin(8-13) [CAS 60482-95-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P0251-5mg
|
MedChemexpress LLC
|
Neurotensin(8-13) [CAS 60482-95-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1290A-10mg
|
MedChemexpress LLC
|
PKA Inhibitor Fragment (6-22) amide (TFA)
|
|
Neuroscience-Neuromodulation
|
|
HY-P1290A-5mg
|
MedChemexpress LLC
|
PKA Inhibitor Fragment (6-22) amide (TFA)
|
|
Neuroscience-Neuromodulation
|
|
HY-P4749-500ug
|
MedChemexpress LLC
|
Prion Protein (106-126) (human) (scrambled) [CAS 150469-23-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1530-1mg
|
MedChemexpress LLC
|
Prolactin Releasing Peptide (12-31), human [CAS 235433-36-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1530-500ug
|
MedChemexpress LLC
|
Prolactin Releasing Peptide (12-31), human [CAS 235433-36-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951A-1mg
|
MedChemexpress LLC
|
Ranibizumab (anti-VEGF) [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951A-10mg
|
MedChemexpress LLC
|
Ranibizumab (anti-VEGF) [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951A-5mg
|
MedChemexpress LLC
|
Ranibizumab (anti-VEGF) [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9951-1mg
|
MedChemexpress LLC
|
Ranibizumab [CAS 347396-82-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1485A-10mg
|
MedChemexpress LLC
|
Substance P(1-7) (TFA) [CAS 2828433-22-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1485A-25mg
|
MedChemexpress LLC
|
Substance P(1-7) (TFA) [CAS 2828433-22-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1485A-5mg
|
MedChemexpress LLC
|
Substance P(1-7) (TFA) [CAS 2828433-22-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1921-1mg
|
MedChemexpress LLC
|
YRGDS Fibronectin Fragment [CAS 134282-68-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1921-10mg
|
MedChemexpress LLC
|
YRGDS Fibronectin Fragment [CAS 134282-68-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1921-25mg
|
MedChemexpress LLC
|
YRGDS Fibronectin Fragment [CAS 134282-68-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1921-5mg
|
MedChemexpress LLC
|
YRGDS Fibronectin Fragment [CAS 134282-68-1]
|
|
Neuroscience-Neuromodulation
|
|
HY-P1558A-1mg
|
MedChemexpress LLC
|
ACTH (11-24) (acetate)
|
|
Neuroscience-Neuromodulation
|
|
HY-P1558A-10mg
|
MedChemexpress LLC
|
ACTH (11-24) (acetate)
|
|
Neuroscience-Neuromodulation
|
|